MiCo BioMed Co., Ltd.

KOSDAQ:A214610 Stock Report

Market Cap: ₩60.0b

MiCo BioMed Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for MiCo BioMed.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth35.3%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Is MiCo BioMed (KOSDAQ:214610) Using Too Much Debt?

Aug 08
Is MiCo BioMed (KOSDAQ:214610) Using Too Much Debt?

Is MiCo BioMed (KOSDAQ:214610) Using Debt In A Risky Way?

Apr 12
Is MiCo BioMed (KOSDAQ:214610) Using Debt In A Risky Way?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MiCo BioMed has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A214610 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20248,303-30,008-16,094-15,312N/A
6/30/20247,231-28,950-15,907-14,870N/A
3/31/20246,317-26,814-16,773-15,368N/A
12/31/20235,367-25,774-12,040-11,359N/A
9/30/20235,145-33,168-12,594-11,779N/A
6/30/20235,691-34,801-13,740-12,952N/A
3/31/20238,261-39,764-19,142-17,892N/A
12/31/202216,111-38,893-15,667-14,006N/A
9/30/202221,617-26,305-13,863-11,648N/A
6/30/202226,477-22,378-15,052-12,463N/A
3/31/202227,117-16,269-11,450-8,536N/A
12/31/202130,302-10,575-11,731-8,600N/A
9/30/202135,7362,899-17,415-11,758N/A
6/30/202141,1067,358-18,564-12,761N/A
3/31/202156,823-961-20,315-13,959N/A
12/31/202045,672-5,776-24,701-18,679N/A
12/31/20194,098-14,632-11,988-10,435N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A214610's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A214610's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A214610's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A214610's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A214610's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A214610's Return on Equity is forecast to be high in 3 years time


Discover growth companies